Tech Company Financing Transactions
SFJ Pharmaceuticals Funding Round
Clarus, Abingworth and private investors invested in a $45 million Series A capital raise for SFJ Pharmaceuticals. This venture round was announced on 3/16/2009.
Transaction Overview
Company Name
Announced On
3/16/2009
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series A
Investors
Clarus (Lead Investor) (Kurt Wheeler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5000 Hopyard Rd. 330
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
SFJ Pharmaceuticals Inc is a platform for bringing U.S. and European drugs to Japan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert DeBenedetto
Chief Financial Officer
Bruce Bouchard
Chief Medical Officer
Rolf Linke
Chief Operating Officer
Stewart Hallett
Executive Vice President
Alexander Dilis
VP - Bus. Development
Geoff Owen
VP - Bus. Development
Fumito Tsuji
Browse more venture capital transactions:
Prev: 3/16/2009: Pubmatic venture capital transaction
Next: 3/17/2009: Zeugma Systems venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs